Rapid Tests Sars -Cov-2 -Covid-19

COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains:
GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request.

To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away.
1. Nasopharyngeal
2. Nasal
3. Saliva

Price and Minumum Quantity
Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces
Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet
Sample: Available. Sample Cost Born By Supplier
Product Model And Origin
Brand: GENEDIAModel: 643G-S (Saliva)
Seller Code: Genedia w covid 19 agHS Code: 3002.15
Standards: Ce
Competitive Advantages
Allow wider testing with fast test time (10 minutes)
All necessary materials provided / no equipment needed
Sensitivity: 93.33%, specificity: 100%
Free sample. no moq. price is negotiable. customized packing.
Other Details
20 tests / kit
24 months from the date of manufacture
2 ~ 30c(35.6 ~ 86f) available for room temperature deliver
In stock. fast delivery.
1 x Instructions for Use Manual
40 x Test Cassettes
1 x Buffer
40 x Dropper

Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.

Price and Minumum Quantity
Price FOB in USD: NegotiableMinimum Order Qty: 10000
Production Capacity: 1000000Packaging: 25 Persons/box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: Easysweet
HS Code: 3822009020
Standards: Ce
Competitive Advantages
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Other Details
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)

Covd-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and dierential detection of IgG and IgM antibodies to 2019 Novel Corona Virus in human whole blood, serum or plasma.



Specification.jpg

Product: Rapid Diagnostic Test Kit

Item: Corona Virus Test Kit

Specimen: Whole Blood/Serum/Plasma

Format: Strip/Cassette

Port of Loading: Shanghai

OEM and ODM: OEM/ODM Welcome

Shipping: By UPS, FEDEX, DHL, TNT, by air or by sea

MOQ for Private label: Low MOQ 1600 boxes, Please contact us.

Note: Store this product in a cool and dry place, avoid direct sunlight, stay away from places that children can contact, and avoid eye contact. If you have allergies to this product, please stop using and consult a doctor.

COVID-19 Corona Virus Rapid Test Kit11.pngCOVID-19 Corona Virus Rapid Test Kit12.png

Access Bio Care Start Covid-19 Rapid Antigen Test Kit

Product Details:
Number of Reactions(Preps) per Kit : 1
Brand : Access Bio
Test Method : Antigen Test
Result Time (Rapid Kits) : 10 min
Sample Type ; Nasal Swab
Packaging Size : 20 Test Kits/Box
Packaging Type : Box
The CareStart COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between

For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.

1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.

Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box

Covid -19 Test Kit (Colloidal Gold Method)
For Self-testing Use (Nasal Swab)
Top 10 In China Having Ce Mark For Rapid Covid - 19 Antigen Self-test


Precise Rapid Sensitive
For At-home Testing
For Early Detection
Able To Sell Across All Eu Member States

Intended use:
AIVD COVID-19(SARS-CoV-2) IgG/IgM Rapid Test is a single use, rapid device for qualitative detection of total antibodies against 2019 novel coronavirus (SARS-CoV-2) in human serum, plasma or whole blood specimens. The kit is intended for screening of patients suspected for infection with SARS-CoV-2, and as an aid in the diagnosis of the coronavirus disease 2019 (COVID-19).

Descriptionï¼?
Novel coronavirus pneumonia (NCP) or SARS-COV-2, that was officially named by the WHO as â??Corona virus disease 2019â?? (COVID-19), is a respiratory infection caused by a new virus that was first identified in late 2019.

IgM/IgG Rapid Kit can specifically detect IgM and IgG antibodies of COVID-19, covering the entire course of infection and recovery period of patients. This approach improves the overall diagnosis of COVID-19 in both acute and recovery phases of illness.

This kit utilizes the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) IgG / IgM antibodies in human serum and plasma. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients.

This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well, and then add the required amount of a diluent. The IgG / IgM antibodies in the sample will interact with the colloidal gold-labeled COVID-19 recombinant antigen on the conjugate pad. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward.
As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COVID-19 IgG antibodies, they will bind to the colloidal gold-labeled novel coronavirus recombinant antigen, diffuse forward, and then react with the anti-human IgG antibodies immobilized on the NC membrane detection line (T2 line). Similarly, if the specimen contains IgM antibodies to COVID-19, the antibodies will react with antigen-coated particles, the conjugate migrate laterally forward, and cause a colored line (T1 line). The darker the color of colloidal gold on the test line, the higher the concentration antibodies to COVID-19 in the sample.

Accuracy:ï¼?> 90%
Specificity: 97%


Basic Protocolï¼?
1. Remove the test specimen, required reagents from storage conditions, and equilibrate to room temperature.
2. Unpack the aluminum foil bag, place the test horizontally on the table and number it.
3. Add 10ul serum, plasma or whole blood sample to the sample well with a pipette or a dropper. Slowly add 2 drops of sample dilution (about 60uL) to the sample well.
4. Read the results within 10-15 minutes after adding the sample, and the results will be invalid after 30 minutes.

AIVD Biotechs COVID-19 Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen from SARS-CoV-2 in direct nasal swabs from individuals suspected of COVID-19.

Description
This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the new coronavirus (COVID-19) Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients.
The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to SARS-CoV-2 antigen on the test lines (T). If SARS-CoV-2 antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly.
This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled COVID-19 anti-SARS-COV-2 NP antibodies on the conjugate pad.

Required components
1. A foil pouch with a desiccant and a single-use test card, 1 piece
3. Sterile swab, 1 piece
3. Extraction buffer tube (1 ml), 1 tube.
4. Instructions for use, 1 piece.

Specimen requirements:
1. Nasopharyngeal swab specimen.
2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8â?? for up to 4 hours prior to testing.

Specimen preparation
1. Insert the extraction buffer tube into the tube rack, make sure that the sample tube is firmly upright and touches the bottom of the rack.
2. Insert the swab into an extraction buffer tube.
3. Gently stir the swab in the tube, and then left swab inside the tube for 1 minute or Mix on the vortex mixer for about 30 seconds,
4. The sample should be tested immediately after collection.
If it cannot be tested in time, it should be stored in the virus transport matrix. The specimens can be stored at 2-8C for 4 hours

Basic Protocol
Step 1: If the sample is refrigerated, remove the sample to be tested and the required reagents from the storage conditions, equilibrate to room temperature (15~30C)
Step 2: When preparing to test, open the aluminum foil bag, take out the test card, and lay it flat on a table.
Step 3: Mark the sample number on the test card,
Step 4: Using pipette add 50ul of the sample into a sample well on the device,
Step 5: Read the result within 15 minutes,
Please read the result after 15 minutes. After observing and recording the result, please discard the test card to avoid affecting the result judgment.
Do not read test results after 30 minutes. It may give false results.

Anti-SARS-CoV-2 Rapid Test, COVID-19
1. Easier: No special equipment needed, Intuitive visual interpretation.
2. Rapid: Quick sampling by fingertip blood, Results in 10-15min.
3. Accurate: Results with IgG and IgM respectively.
4. Application: as screening tool for potential suspect patients in large numbers.

Testing kit is FDA Emergency Use Authorization (EUA) Approved
Testing kit is CE MARKED-IVD

* Instruction for Use
* Interpretation Guide
* SARS-CoV-2 immunoassays
* Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit
* Anti-SARS Rapid Test Brochure
* COVID-19 Catalog
* EUA Approval Letter
* Fact Sheet for Healthcare Providers
* FDA Letter
* Fact Sheet for Recipients
* FAQ
* CE IVD Notification Certificate

Antibody Performance Measure Estimate of Performance 95% Confidence Interval
IgM Sensitivity (PPA) 95.7% (289/302) (92.8%; 97.5%)
IgM Specificity (NPA) 99.7% (311/312) (98.2%; 99.9%)
IgG Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%)
IgG Specificity (NPA) 99.4% (310/312) (97.7%; 99.8%)
Combined Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%)
Combined Specificity (NPA) 99% (309/312) (97.2%; 99.7%)
Combined PPV at prevalence = 5% 84.4% (64.6%; 94.6%)
Combined NPV at prevalence = 5% 99.9% (99.8%; 100%)
Testing kit is FDA Emergency Use Authorization (EUA) Approved
Testing kit is CE MARKED-IVD

* Instruction for Use
* Interpretation Guide
* SARS-CoV-2 immunoassays
* Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit
* Anti-SARS Rapid Test Brochure
* COVID-19 Catalog
* EUA Approval Letter
* Fact Sheet for Healthcare Providers
* FDA Letter
* Fact Sheet for Recipients
* FAQ
* CE IVD Notification Certificate